SCHEMBL4709858

SCHEMBL4709858

COc1ccc(C[C@H](C)N2CCN(c3ccc(Cl)c(C(F)(F)F)c3)CC2)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.68
MAPT P10636 2/20 0.68
POLB P06746 1/20 0.55
KMT2A Q03164 2/20 0.53
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
CCR1 P32246 3/20 0.40
PHGDH O43175 1/20 0.40
NOTUM Q6P988 1/20 0.39
MC4R P32245 1/20 0.39
GFER P55789 1/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710185 1.00 SMN1; SMN2 (0.68) SMN1; SMN2MAPTPOLBKMT2AHSD17B10
SCHEMBL4710495 1.00 SMN1; SMN2 (0.68) SMN1; SMN2MAPTPOLBKMT2AHSD17B10
SCHEMBL4711818 0.84 DRD2 (0.58) SMN1; SMN2MAPTKMT2AHSD17B10ALDH1A1
SCHEMBL5849758 0.83 SMN1; SMN2 (0.46) SMN1; SMN2MAPTKMT2AHSD17B10MEN1
SCHEMBL4708524 0.83 SMN1; SMN2 (0.46) SMN1; SMN2MAPTKMT2AHSD17B10MEN1
SCHEMBL14453013 0.83 SMN1; SMN2 (0.46) SMN1; SMN2MAPTKMT2AHSD17B10MEN1
SCHEMBL5183039 0.82 EBP (0.50) SMN1; SMN2MAPTHSD17B10ALDH1A1KDM4E
SCHEMBL4710567 0.81 SMN1; SMN2 (0.47) SMN1; SMN2MAPTKMT2AHSD17B10ALDH1A1
SCHEMBL5182420 0.80 EBP (0.54) SMN1; SMN2MAPTALDH1A1KDM4ENPSR1
SCHEMBL4710459 0.79 HSD17B10 (0.44) SMN1; SMN2MAPTKMT2AHSD17B10CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1935885-A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. NEUROGEN CORPORATION (US) 2008-06-25 EP disclosed
US-7081458-B2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues NEUROGEN CORP. (US) 2006-07-25 US disclosed
US-6953801-B2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues NEUROGEN CORPORATION (US) 2005-10-11 US disclosed
US-20050182068-A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues HUTCHISON ALAN (US) 2005-08-18 US disclosed
US-20050065162-A1 MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES NEUROGEN CORPORATION 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065162-A1 MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES MCHR1, MCHR2, MC1R SMN1; SMN2 1441/4885MAPT 2914/4885POLB 4648/4885
US-20050182068-A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues MCHR1, MCHR2, MC1R SMN1; SMN2 1441/4885MAPT 2914/4885POLB 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.